Today: 11 June 2026
Bitcoin slips below $89,000 as ETF withdrawals and rate jitters curb demand
23 January 2026
1 min read

Bitcoin slips below $89,000 as ETF withdrawals and rate jitters curb demand

New York, Jan 23, 2026, 10:15 ET — Regular session

  • Bitcoin slipped under $89,000 as traders held back ahead of a packed week of central bank events
  • U.S.-listed spot bitcoin ETFs saw net outflows continue in recent sessions
  • Investors are focused on the Fed’s Jan. 27-28 meeting for hints on rate moves and shifts in risk appetite

Bitcoin slipped below $89,000 on Friday, dropping 0.7% to $88,725 as traders pulled back from risk. Ether also dropped, down 0.5% to $2,914, per CME CF real-time indices.

After a turbulent stretch in currencies, rates and commodities, gold surged to a new peak near $4,967 an ounce. The yen’s volatility was fueled by intervention jitters, while Japanese two-year bond yields climbed to 1.25%, their highest level since 1996, according to Reuters data.

This week’s action shows bitcoin still behaves like a risk asset amid market jitters, not a safe haven. Samer Hasn, senior market analyst at XS.com, called it “a geopolitical roller coaster” driving crypto’s recent slide, with rising yields adding to the pressure. Liquidations — forced closures of leveraged positions — have surged since bitcoin failed to stay above $90,000, noted Wenny Cai of SynFutures. MarketWatch

Flows have worked against the market. U.S. spot bitcoin ETFs—those holding bitcoin and trading on exchanges—experienced net outflows of $708.7 million on Jan. 21 and another $32.2 million on Jan. 22, according to Farside Investors data. The bulk of selling hit the largest funds.

Some investors chasing “hard” assets are now treating bitcoin like bullion. On Thursday, Bitwise and Proficio Capital Partners rolled out a “currency debasement” ETF combining gold, bitcoin, and other metals, with gold making up at least 25%. Proficio’s Bob Haber described the blend as “their own asset class” and called the move toward “hard currencies” a “long-term secular shift.” Reuters

The tug-of-war is clear: gold continues to attract the traditional safe-haven flow, while bitcoin’s rally hinges on investors’ appetite for risk and their willingness to leverage positions.

Here’s the downside: if bond yields climb higher or stocks falter again, crypto could face fresh waves of forced selling, with ETF redemptions potentially making the sell-off worse.

Traders are now focused on the Federal Reserve. The central bank’s two-day meeting wraps up Jan. 28, with the rate announcement set for 2:00 p.m. ET. Chair Jerome Powell will speak at 2:30 p.m., according to the Fed’s schedule.

Stock Market Today

  • Top Software Stocks Set for Rally in Second Half, Says BofA
    June 11, 2026, 11:15 AM EDT. Bank of America (BofA) has identified leading software stocks poised for a significant rally in the second half of the year. While specific companies were not detailed, BofA's outlook highlights growth potential in the tech sector amid evolving market conditions. Investors are closely watching software firms as demand for digital solutions continues to expand, driven by cloud computing and enterprise software trends. This bullish stance from a major financial institution underscores confidence in software stocks as key components of portfolio growth strategies moving forward.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Micron stock rises as new bullish call hits tape; investors eye insider sale plan
Previous Story

Micron stock rises as new bullish call hits tape; investors eye insider sale plan

Apple stock price slips today: What’s moving AAPL ahead of next week’s catalysts
Next Story

Apple stock price slips today: What’s moving AAPL ahead of next week’s catalysts

Go toTop